Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells

Journal of Cellular Physiology

Volumn 214, Issue 2, 2008, Pages 537-544

  Clarkin, Claire E ^a   Emery, Roger J ^b   Pitsillides, Andrew A ^a   Wheeler Jones, Caroline P D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ALKALINE PHOSPHATASE; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANTIBODY LABELING; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ACROMION; ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; CULTURE MEDIA; DINOPROSTONE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPIDERMAL GROWTH FACTOR; EPOPROSTENOL; FEMALE; FEMUR; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT DYES; HUMANS; INTERLEUKIN-1ALPHA; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; OSTEOCALCIN; PARACRINE COMMUNICATION; PROPIDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 37349095299     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21234     Document Type: Article

References (57)

1. Abedi H, Zachary I. 1997. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272:15442-15451.
2. Akeno N, Robins J, Zhang M, Czyzyk-Krzeska MF, Clemens TL. 2002. Induction of vascular endothelial growth factor by IGF-1 in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2{alpha}. Endocrinology 143:420-425.
3. Bastow ER, Lamb KJ, Lewthwaite JC, Osborne AC, Kavanagh E, Wheeler-Jones CPD. Pitsillides AA. 2005. Selective activation of the MEK-ERK pathway is regulated by mechanical stimuli in forming joints and promotes pericellular matrix formation. J Biol Chem 280:11749-11758.
4. Bittner K, Vischer P, Bartholmes P, Bruckner P. 1998. Role of subchondral vascular system in endochondral ossification: Endothelial cells specifically depress late differentiation in resting chondrocytes in vitro. Exp Cell Res 238:491-497.
5. Blume ED, Taylor CT, Lennon PF, Stahl GL, Colgan SP. 1998. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest 102:1161-1172.
6. Brandi ML, Collin-Osbody P. 2006. Vascular biology and the skeleton. J Bone Miner Res 21:182-192.
7. Brown RA, Rees JA, Mcfarland CD, Lewinson D, Ali SY. 1990. Microvascular invasion of rabbit growth plate cartilage and the influence of dexamethasone. J Bone Miner Res 9:35-47.
8. Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Shalag R, Frisch B, Mallmann B, Eisenmenger W, Gilg TH. 1987. Changes in trabecular bone hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis and old age: A comparative histomorphometric study. Bone 8:564-571.
9. Carringdon JL, Reddi AH. 1991. Parallels between development of embryonic and matrix induced endochondral bone. Bioessays 13:403-406.
10. Chang HJ, Park JS, Kim MH, Hong MH, Kim KM, Kim SM, Shin BA, Ahn BW, Jung YD. 2006. Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells. Int J Oncol 28:135-141.
11. Cheng L, Jia H, Lohr M, Bagherzadeh A, Holmes DIR, Selwood D, Zachary I. 2004. Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated by neuropilin-1 and cyclooxygenase-derived prostanoid production. J Biol Chem 279:30654-30661.
12. Colgan SP, Taylor CT, Narravula S, Synnestvedt K, Blume ED. 2002. Endothelial COX-2 induction by hypoxia liberates 6-ketoPGF1a, a potent epithelial secretagogue. Adv Exp Med Biol 507:107-112.
13. Deckers B, Bartels H, Deckers S. 1995. Relationships between endothelial cells, pericytes and osteoblasts during bone formation in the sheep femur following inplantation of tricalciumphosphate ceramic. Anat Rec 242:310-320.
14. Deckers MML, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW. 2000. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667-1674.
15. Elbjeirami WM, West JL. 2006. Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells. Tissue Eng 12:381-390.
16. Esbrit P, Alvarez-Arroyo M, De Miguel F, Martin O, Martinez M, Caramelo C. 2000. C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol 11:1085-1092.
17. Ferrara N. 1996. Vascular endothelial growth factor. Eur J Cancer 32A:2413-2422.
18. Fong KD, Nacamuli RP, Loboa EG, Henderson JH, Fang TD, Song HM, Cowan CM, Warren SM, Carter DR, Longaker MT. 2003. Equibiaxial tensile strain affects calvarial osteoblast biology. J Craniofac Surg 14:48-55.
19. Fons P, Herault JP, Delesque N, Tuyaret J, Bono F, Herbert JM. 2004. VEGF-R2 and neuropilin-1 are involved in VEGF-A- induced differentiation of human bone marrow progenitor cells. J Cell Physiol 200:351-359.
20. 2 by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. J Bone Miner Res 20:681-682.
21. Gerber H-P, Ferrara N. 2000. Angiogenesis and bone growth. Trends Cardiovasc Med 10:223-228.
22. Gerber H, Vu TH, Ryan A, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
23. Gliki G, Abu-ghazaleh R, Jezequel S, Wheeler-jones C, Zachary I. 2001. Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC- and by mobilization of intracellular Ca2+. J Biochem 535:503-512.
24. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR. 2006. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281:26320-26328.
25. Haider DG, Bucek RA, Giurgea AG, Maurer G, Glogar H, Minar E, Wolzt M, Mehrabi MR, Baghestanian M. PGEI analog alprostadil induces VEGF and eNOS expression in endothelial cells. Am J Physiol Heart Circ Physiol 2005. 289:H2066-H2072.
26. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Meisen F. 2001. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16:1575-1582.
27. 2 synthesis in endothelium. Am J Physiol Cell Physiol 281:C1266-C1276.
28. Houliston RA, Keogh RJ, Sugden D, Dudhia J, Carter TD, Wheeler-Jones CPD. 2002. Protease-activated receptors upregulate cyclooxygenase-2 expression in human endothelial cells. J Thromb Haemost 88:321-328.
29. Hwang D, Scollard D, Byrne J, Levine E. 1998. Expression of cycoloxygenase 1 (COX-1) and cycoloxygenase 2 in human breast cancer. J Natl Cancer Inst 90:455-460.
30. Li J, Burr DB, Turner CH. 2002. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading. Calcif Tissue Int 70:320-329.
31. 2. Mol Pharmacol 60:36-41.
32. Mayr-wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther K-P, Dehio C, Puhl W, Brenner RE. 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472-477.
33. Midy V, Plouet J. 1994. Vasculotropin/vascular endothelial growth factor induces differentiation cultured osteoblasts. Biochem Biophys Res Commun 199:380-386.
34. Milkiewicz M, Mohammadzadeh F, Ispanovi E, Gee E, Haas T. 2007. Static strain stimulates expression of matrix metalloproteinase-2 and VEGF in microvascular endothelium via JNK- and ERK-dependent pathways. J Cell Biochem 100:750-761.
35. Muir C, Leland WK, Chung LW, Carson DD, Farach-Carson M. 2006. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis 23:75-86.
36. 165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J Biol Chem 280:9904-9912.
37. Okada Y, Tomita M, Gronowicz G, Kawaguchi H, Sohn J, Tanaka Y, Morimoto I. 2000. Effects of COX-2 gene disruption on osteoblastic function. J Bone Miner Res 15:S217 (abstract).
38. Pitsillides AA, Rawlinson SC, Mosley JR, Lanyon LE. 1999. Bone's early responses to mechanical loading differ in distinct genetic strains of chick: Selection for enhanced growth reduces skeletal adaptability. J Bone Miner Res 14:980-987.
39. Pufe T, Scholz-Ahrens KE, Franke ATM, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Gluer CC. 2003. The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: Evaluation in a minipig model. Bone 33:869-876.
40. Rawlinson SCF, Wheeler-Jones CPD, Lanyon LE. 2000. Arachidonic acid for loading induced prostacyclin and prostaglandin E2 release from osteoblasts and osteocytes is derived from the activities of different forms of phospholipase A2. Bone 27:241-247.
41. Schneider M, Buchler P, Giese N, Giese T, Wilting J, Buchler MW, Friess H. 2006. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Int J Oncol 28:883-890.
42. Shapiro IM, Boyde A. 1987. Mineralisation of normal and rachitic chick growth cartilage: Vascular canals, cartilage calicification and osteogenenesis. Scanning Microsc 1:599-606.
43. Stein GS, Lian JB, Owen TA. 1990. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111-3123.
44. Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Paleolog E, Wheeler-Jones CPD. 2006. Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-{kappa}B pathways. J Biol Chem 281:11792-11804.
45. Takahashi T, Ueno H, Shibuya M. 1999. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase for DNA synthesis in primary endothelial cells. Oncogene 18:2221-2230.
46. Tombran-Tink J, Barnstable CJ. 2004. Osteoblast and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: Possible mediators of angiogenesis and matrix remodelling in bone. Biochem Biophys Res Commun 316:573-579.
47. Trueta J. 1963. The role of the vessels in osteogenesis. J Bone Joint Surg 45-B:402-418.
48. Trueta J, Little K. 1960. The vascular contribution to osteogenesis. II. Studies with the electron microscope. J Bone Joint Surg 42:367-376.
49. Varney ML, Olsen KJ, Mosley RL, Singh RK. 200S. Paracrine regulation of vascular endothelial growth factor - a expression during macrophage-melanoma cell interaction: Role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 25:674-683.
50. Wang DS, Yamazazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K. 1996. Increase of vascular endothelial growth factor mRNA expression produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138:2953-2962.
51. Wang DS, Miura M, Demura H, Sato K. 1997. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138:2953-2962.
52. Wheeler-Jones CPD, Abu-Ghazaleh R, Cospedal R. 1997. Vascular endothelial growth factor stimulates prostacylin production and activation of cytosolic phospholipase A in endothelial cells via p42/p44 mitogen activated kinase. FEBS Lett 353:503-512.
53. Xia G, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. 1997. Characterisation of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms and endothelial cell growth. J Clin Invest 98:2018-2026.
54. Zaman G, Pitsillides AA, Rawlinson SC, Suswillo RF, Mosley JR, Cheng MZ, Platts LA, Hukkanen M, Polak JM, Lanyon LE. 1999. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res 14:1123-1131.
55. Zelzer E, McLean W, Ng Y-S, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR. 2002. Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893-1904.
56. Zeng H, Dvorak HF, Mukhopadhyay D. 2001. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 276:26969-26979.
57. Zhang X, Schwartz EM, Young DA, Puzas E, Rosier RN, O'Keefe RJ. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.